Search results
Story from Associated Retina Consultants: Local group helps macular degeneration patients cope with...
The Arizona Republic· 3 days agoAccording to the Centers for Disease Control and Prevention (CDC), nearly 20 million Americans over...
Dear Doctor: Can I use over-the-counter eye drops while on medications for macular degeneration?
OregonLive.com· 4 days agoROACH: I am a healthy 67-year-old female being treated with Eylea for wet age-related macular degeneration (AMD). Is it safe to use over-the-counter ...
Breakthrough Study Reveals Somavedic Device's Potential Impact on Wet AMD Patients
WTNH-TV New Haven· 6 days agoThe study enrolled patients with newly diagnosed wet AMD and active choroidal neovascularization (CNV), where anti-VEGF therapy was indicated.
PharmAbcine's U.S. Subsidiary, Wincal Biopharm, to Present Preclinical Data from its Proprietary OPC...
ABC 26 New Orleans· 7 days agoPharmAbcine, Inc. ("PharmAbcine" or the "Company") (KOSDAQ: 208340), a clinical-stage public company developing next generation therapeutics to treat medical unmet needs, announced today that ...
Health Care Roundup: Market Talk
The Wall Street Journal· 7 days agoMoreover, its planned launch of aflibercept—for patients living with wet macular degeneration—could be a potentially significant biosimilar ...
2 Small-Cap Growth Stocks With Room to Run
Motley Fool via Yahoo Finance· 5 days agoCurrently, Wall Street analysts believe the company's shares could be undervalued by as much as 210%. The reason? Ocular is developing a novel therapy...
Top 20 biopharma kick off 9.6% market cap surge in Q1 2024 amid Medicare price talks
Pharmaceutical Technology via Yahoo Finance· 3 days agoHowever, Roche’s market capitalisation fell by 12.4%, largely attributed to the decline in demand...
Truist Financial Corp Sells 8,062 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
ETF DAILY NEWS· 12 hours agoTruist Financial Corp reduced its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 15.4% in the fourth quarter, according to the company in its most recent ...
Sigma Planning Corp Reduces Stake in REGENXBIO Inc. (NASDAQ:RGNX)
ETF DAILY NEWS· 11 hours agoSigma Planning Corp lowered its position in REGENXBIO Inc. (NASDAQ:RGNX – Free Report) by 63.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities ...
Cwm LLC Sells 256 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
ETF DAILY NEWS· 3 days agoCwm LLC lowered its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 9.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange ...